Lightship Inc. Relocates Headquarters to Research Triangle Park, North Carolina
Move reinforces long-term investment in the life sciences ecosystem and supports the site organization’s next phase of growth
RESEARCH TRIANGLE PARK, NC – January 26, 2026 – Lightship Inc., the modern clinical trial site organization committed to making research possible for all, announced today that it has relocated its headquarters to Research Triangle Park (RTP), North Carolina. The move strengthens day-to-day collaboration across the company’s leadership and operational teams as Lightship continues to scale.
Lightship’s expanded access site model supports clinical trials across in-clinic, hybrid, and virtual settings through one trusted partner. By aligning each visit to the most practical setting, Lightship helps trial teams support protocol requirements while reducing operational complexity, improving participant retention, and strengthening representation across diverse communities.
“Relocating our headquarters to RTP reflects where we are today as well as where we’re going,” said David MacMurchy, Chief Executive Officer of Lightship. “As a life science hub, the RTP region brings together clinical research expertise, operational talent, and an ecosystem built for collaboration. It’s a strong fit for our mission and a practical base as we continue to scale high-quality trial execution.”
“This move strengthens how we operate day to day and connects us to a deep talent pool in clinical research and operations,” said Darcy Forman, Chief Operating Officer of Lightship. “As we grow, we stay anchored in consistent oversight, unified processes, and a smooth participant experience across every setting, whether that’s in-clinic, at home, or in the community.”
Lightship’s approach is supported by experienced investigators and study teams, unified SOPs, and the ability to integrate with sponsors’ preferred technology platforms and workflows. The company’s capabilities include physical sites, home visits supported by Lightship nursing staff, and Mobile Research Units (MRUs) that extend access through community-based education, recruitment, prescreening, and select study visits.
“RTP gives us access to exceptional talent, and I’m genuinely excited to continue building a strong team here,” said Michael Shipton, Chief Business Officer of Lightship. “This is an ecosystem that supports our commitment to sponsors and CROs: to deliver the kind of trial performance that earns long-term partnerships.”
The move to RTP follows Lightship’s recent go-to-market evolution and reinforces the company’s commitment to scaling its flexible site model as a practical approach to trial execution for sponsors, CROs, and participants alike.
About Lightship Inc.
Lightship Inc. is a modern clinical trial site organization committed to making research participation possible for all. We collaborate with biopharma and CROs to design and conduct studies that expand access and choice while accelerating new therapies. Through in-clinic, at-home, and mobile research unit visits, we support individuals from first contact to completion and deliver shorter timelines, stronger participant retention, greater diversity, and consistent quality and safety. At Lightship, we redefine what it means to be a clinical trial site. For more information, visit https://lightship.com.
###
Contact: Brittany Kearns
Phone: 571-271-7211
Email: brittany@crossroadsb2b.com